Prognostic value of lymphocyte-to-monocyte ratio in the patients with malignant tumor
10.11904/j.issn.1002-3070.2017.02.019
- VernacularTitle:淋巴细胞/单核细胞比值对恶性肿瘤患者预后评估的研究进展
- Author:
Aiqi ZHANG
;
Shi JIN
;
Shoubo CAO
- Keywords:
Lymphocyte-to-monocyte ratio;
Tumors;
Prognosis;
Inflammatory factor
- From:
Practical Oncology Journal
2017;31(2):188-192
- CountryChina
- Language:Chinese
-
Abstract:
Inflammation has a critical role in the pathogenesis and progression of cancer.lymphocyte and monocyte play an important role in inflammatory reaction,reflecting body immune status.In recent years,more and more clinical studies have shown that pretreatment of lymphocyte-to-monocyte ratio(LMR)in the patients with malignant tumor may have a certain value in evaluating the prognosis of cancer patients such as nasopharyngeal cancer,esophageal cancer,breast cancer,ovarian cancer,lung cancer,gastric cancer,colorectal cancer,etc.This article reviews the latest research progress on the value of LMR in the evaluation of the prognosis of the patients with malignant tumor.
